Advanced Oncotherapy (AVO) – COO and CFO Nicolas Serandour is interviewed by BRR Media, and provides an update on AVO’s recent activity including the agreement with Thales and the companies financial strategy. Link here to listen.
Home » Advanced Oncotherapy (AVO) » Advanced Oncotherapy (AVO) – Strategic Update from Nicolas Serandour